BCAN and oligodendroglioma: A pilot study on 5 matched 1p/19 co-deleted and 1p/19q non-deleted oligodendrogliomas revealed Brevican core protein (BCAN) and Serotransferrin (TRFE) as possible biomarkers for the co-deleted 1p/19q phenotype [48].